Viridian Therapeutics, Inc. (VRDN): This Small-Cap Stock Is Ready To Explode

Published on 19 Nov 2024 on Insider Monkey · via Yahoo Finance

We recently compiled a list of the 10 Best Small-Cap Stocks Ready To Explode. In this article, we...

Read the rest of the article

Start tracking your investments with Statfolio

Key Insights The projected fair value for Viridian Therapeutics is US$14.53 based on 2 Stage Free...

Simply Wall St. · via Yahoo Finance 25 Dec 2024

We recently compiled a list of the 10 Best Small-Cap Stocks Ready To Explode. In this article, we...

Insider Monkey · via Yahoo Finance 19 Nov 2024

Overview of the Recent Trade On September 30, 2024, State Street Corp executed a significant tran...

GuruFocus.com · via Yahoo Finance 18 Oct 2024

We recently compiled a list of the Top 10 Small-Cap Stocks with Highest Upside Potential. In this...

Insider Monkey · via Yahoo Finance 24 Jun 2024

Viridian Therapeutics, Inc. (NASDAQ:VRDN) Q1 2024 Earnings Call Transcript May 8, 2024 Viridian T...

Insider Monkey via Yahoo Finance 9 May 2024

Revenue: Reported at $72,000 for Q1 2024, surpassing the estimated $70,000.Net Loss: Recorded at ...

GuruFocus.com via Yahoo Finance 8 May 2024

Viridian Therapeutics, Inc. (VRDN) came out with a quarterly loss of $0.79 per share versus the Z...

Zacks via Yahoo Finance 8 May 2024

Shares of Viridian Therapeutics, Inc. (VRDN) have gained 0.4% over the past four weeks to close t...

Zacks via Yahoo Finance 28 Feb 2024

Viridian Therapeutics, Inc. (VRDN) came out with a quarterly loss of $1.09 per share versus the Z...

Zacks via Yahoo Finance 13 Nov 2023

Viridian Therapeutics Inc (NASDAQ:VRDN) continues enrollment for THRIVE and THRIVE-2 clinical tri...

GuruFocus.com via Yahoo Finance 13 Nov 2023